The Ca2+-activated chloride channel ANO1/TMEM16A: An emerging therapeutic target for epithelium-originated diseases?
Acta Pharm Sin B
; 11(6): 1412-1433, 2021 Jun.
Article
in En
| MEDLINE
| ID: mdl-34221860
ANO1; ANO1, anoctamin-1; ASM, airway smooth muscle; Ang II, angiotensin II; BBB, bloodbrain barrier; CAMK, Ca2+/calmodulin-dependent protein kinase; CF, cystic fibrosis; CFTR, cystic fibrosis transmembrane conductance regulator; Ca2+-activated Cl channels (CaCCs); CaCCinh-A01; CaCCs, Ca2+ activated chloride channels; Cancer; Cystic fibrosis; DRG, dorsal root ganglion; Drug target; EGFR, epidermal growth factor receptor; ENaC, epithelial sodium channels; ER, endoplasmic reticulum; ESCC, esophageal squamous cell carcinoma; FRT, fisher rat thyroid; GI, gastrointestinal; GIST, gastrointestinal stromal tumor; GPCR, G-protein coupled receptor; HNSCC, head and neck squamous cell carcinoma; HTS, high-throughput screening; ICC, interstitial cells of Cajal; IPAH, idiopathic pulmonary arterial hypertension; MAPK, mitogen-activated protein kinase; NF-κB, nuclear factor κB; PAH, pulmonary arterial hypertension; PAR2, protease activated receptor 2; PASMC, pulmonary artery smooth muscle cells; PIP2, phosphatidylinositol 4,5-bisphosphate; PKD, polycystic kidney disease; T16Ainh-A01; TGF-ß, transforming growth factor-ß; TMEM16A; VGCC, voltage gated calcium channel; VRAC, volume regulated anion channel; VSMC, vascular smooth muscle cells; YFP, yellow fluorescent protein
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Acta Pharm Sin B
Year:
2021
Document type:
Article
Affiliation country:
China
Country of publication:
Países Bajos